Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
---|
08/22/2007 | CN101023086A Selected fused heterocyclics and uses thereof |
08/22/2007 | CN101023063A Azine-carboxamides as anti-cancer agent |
08/22/2007 | CN101020677A Cyanoacrylate compounds and their application in pesticide |
08/21/2007 | US7259260 Aromatic ring system with a quinazoline-4-on group linked to the carbon between the dione group, and a metallocenyl group bonding to the nitrogen atom of the imide group via a bivalent aromatic ring |
08/21/2007 | US7259163 Viricides against herpes virus |
08/21/2007 | US7259155 Phosphonic diester derivatives |
08/21/2007 | CA2150940C Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
08/16/2007 | WO2007092190A2 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity |
08/16/2007 | WO2007091683A1 Bissquarylium compound |
08/16/2007 | WO2007091622A1 Anti-cancer pharmaceutical composition |
08/16/2007 | WO2007090793A1 Nitrooxy-comprising derivatives of apraclonidine and brimodnidine as al pha2 -adrenergic receptor agonists |
08/16/2007 | WO2007090748A1 Benzamide and heteroarene derivatives |
08/16/2007 | WO2007041365B1 3-cyclyl-2- (4-sulfamo yl-phenyl) -n-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes |
08/16/2007 | WO2004007437A9 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
08/16/2007 | US20070191420 Kinase inhibitors |
08/16/2007 | US20070191419 (6R,8S)-6-(spiro[isobenzofuran-1-(3H), 4'-piperidin]-1'-ylmethyl)-5,6,7,8-tetrahydroquinolin-8-ol), exhibiting an antagonism to binding of nociceptin to opioid receptor-like-1 receptors, useful as medicines for diseases associated with pain and appetite control or memory and learning |
08/16/2007 | US20070191407 catalytic chemical preparation of intermediate 4-(2-cyanoethenyl)-2,6-dimethylbenzenamine stereoisomers in presence of palladium chloride; having HIV inhibiting properties |
08/16/2007 | US20070191403 e.g. 3-[{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methylpyrimidine-2,4(1H,3H)-dione; sex-hormone related diseases; anticarcinogenic agent; endometriosis, uterine fibroids, polycystic ovarian disease |
08/16/2007 | US20070191387 Substituted dihydroquinazolines |
08/16/2007 | US20070191380 Kinase inhibitor scaffolds and methods for their preparation |
08/16/2007 | US20070191344 Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases |
08/16/2007 | US20070191333 Antibacterial agents |
08/16/2007 | US20070191318 Process for the preparation of amorphous rosuvastatin calcium |
08/16/2007 | US20070190523 Method and compositions for identifying anti-hiv therapeutic compounds |
08/16/2007 | US20070190355 Material for organic electroluminescence device and organic electroluminescence device utilizing the same |
08/16/2007 | CA2642665A1 Anti-cancer pharmaceutical composition |
08/16/2007 | CA2641501A1 Nitrooxy-comprising derivatives of apraclonidine and brimodnidine as al pha2 -adrenergic receptor agonists |
08/15/2007 | EP1818325A2 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
08/15/2007 | EP1817293A1 Diastereomeric purification of rosuvastatin |
08/15/2007 | EP1816913A1 Novel compounds for treatment of cancer and disorders associated with angiogenesis function |
08/15/2007 | EP1523533B1 Luminescent compositions |
08/15/2007 | EP1355887B1 Pyrimidine acyclonucleoside derivatives, preparation method and use thereof |
08/15/2007 | EP1250137B1 Jak/stat pathway inhibitors and the use thereof for the treatment of primary generalized osteoarthritis |
08/15/2007 | CN1331865C Polymorphs and compositions and methods related thereto |
08/15/2007 | CN1331863C Imide analog compounds and its preparation method |
08/15/2007 | CN1331862C Di-aryl acid derivatives as PPAR receptor ligands |
08/15/2007 | CN101018784A Bicyclic amides as kinase inhibitors |
08/15/2007 | CN101018781A Bicyclic N-anilide spirolactam CGRP receptor antagonists |
08/15/2007 | CN101018772A Neurologically-active compounds |
08/15/2007 | CN101016266A Novel amorphous form of erlotinib hydrochloride and its solid amorphous dispersion |
08/15/2007 | CN101016265A Preparation of HIV-1 reverse transcriptase inhibitor and application thereof |
08/15/2007 | CN101015804A Swollen vermiculite loading NiB amorphous alloy catalyst, its prepn. method and application |
08/14/2007 | US7256288 For therapy or prophylaxis of diseases and for improving perception, concentration, learning and/or memory |
08/14/2007 | US7256287 small molecule inhibitors of the IgE response to allergens that are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic |
08/14/2007 | US7256198 Pyrimidoindolones and methods for using same |
08/14/2007 | US7256197 Methods for synthesis of diarylmethanes |
08/14/2007 | US7256195 Preparation of risperidone |
08/09/2007 | WO2007089768A2 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and pharmaceutical compositions containing them |
08/09/2007 | WO2007089044A1 Process for production of aromatic compound |
08/09/2007 | WO2007088996A1 Trisubstituted amine compounds as inhibitors of -cholesteryl ester transfer protein cetp |
08/09/2007 | WO2007071963A3 Quinazoline derivatives, process for their preparation and their use as anti-cancer agents |
08/09/2007 | WO2007055941A3 Histone deacetylase inhibitors with aryl-pyrazolyl motifs |
08/09/2007 | WO2007038444A3 N-(4-oxo-3,4-dihydroquinazolin-2-yl)butanamides as androgen receptor modulators |
08/09/2007 | US20070185326 Heterocyclic compound |
08/09/2007 | US20070185142 Process for producing substituted aminoquinazolinone derivative, intermediate therefor, and pest control agent |
08/09/2007 | US20070185135 Drug-Polymer Conjugates |
08/09/2007 | US20070185119 Therapeutic agents II |
08/09/2007 | US20070185116 Bicyclic compounds |
08/09/2007 | US20070185091 Bicyclic Heterocycles, Pharmaceutical Compositions Containing These Compounds, Their Use and Processes for Preparing Them |
08/09/2007 | CA2640398A1 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and pharmaceutical compositions containing them |
08/09/2007 | CA2635531A1 Multicyclic amino acid derivatives and methods of their use |
08/08/2007 | EP1816126A1 Process for preparation of rosuvastatin calcium |
08/08/2007 | EP1814867A2 Aryl pyrimidyl compounds, pharmaceutical compositions comprising them, their use as antimicrobial agents |
08/08/2007 | EP1814552A2 Compounds for treating protein-kinase mediated disorders |
08/08/2007 | EP0937050B1 Halogen pyrimidinyl aryl (thio)ethers as pesticides |
08/08/2007 | CN1330657C Novel piperidine and piperazine derivatives |
08/08/2007 | CN1330644C Hydrolysis of [R(R*,R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid esters with calcium hydroxide |
08/08/2007 | CN1330640C Substituted bicyclic derivatives for the treatment of abnormal cell growth |
08/08/2007 | CN1330639C Crystalline pharmaceutical |
08/08/2007 | CN1330634C Antibacterial agents |
08/08/2007 | CN101014604A 6-phenyl-7-amino-triazolopyrimidines, methods for the production thereof, the use thereof for controlling pathogenic fungi, and agents containing the same |
08/08/2007 | CN101014590A 2, 4, 6-trisubstituted pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancer |
08/08/2007 | CN101014576A Aryl spirolactam cgrp receptor antagonists |
08/08/2007 | CN101014564A Substituted acids for the treatment of respiratory diseases |
08/08/2007 | CN101012259A 3'-prodrugs of 2'-deoxy-beta-l-nucleosides |
08/08/2007 | CN101012200A Process for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases |
08/08/2007 | CN101012174A Halogenating agents |
08/07/2007 | US7253292 Synthesis of cyclopentadiene derivatives |
08/07/2007 | US7253286 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
08/07/2007 | US7253192 Phenyl derivatives comprising an acetylene group |
08/07/2007 | US7253177 Synthesis and antimalarial activity of pyrrolo[3,2-f]quinazoline-1,3-diamine derivatives |
08/07/2007 | US7253174 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis. |
08/07/2007 | US7253172 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid |
08/07/2007 | US7253168 Substituted 1-benzyl-4-substituted piperazine analogues |
08/07/2007 | CA2332007C Adenosine a3 receptor modulators |
08/07/2007 | CA2317589C Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
08/02/2007 | WO2007087135A2 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS |
08/02/2007 | WO2007063702A3 Iminopropene compound and use thereof |
08/02/2007 | WO2007056151A3 Protein kinase inhbitors |
08/02/2007 | WO2007047378A3 Dihydrogen phosphate salt of a prostaglandin d2 receptor antagonist |
08/02/2007 | WO2006113304A3 Combinations, methods and compositions for treating cancer |
08/02/2007 | WO2006081391A3 Compounds for inflammation and immune-related uses |
08/02/2007 | US20070179295 Triazolopyrimidines |
08/02/2007 | US20070179263 Functional material comprising fluorine-containing compound |
08/02/2007 | US20070179166 Reduction of statin ketoesters and purification of diol esters of the statins through selective crystallization; rosuvastatin; HMG-CoA inhibitors |
08/02/2007 | US20070179165 Cyclic compounds |
08/02/2007 | US20070179164 Compounds for modulating TRPV3 function |
08/02/2007 | US20070179140 (1R,2R,3S,4S) N4-(3-Aminocarbonylbicyclo[2.2.1]hept-5-ene-2-yl)-5-fluoro-N2-[3-(1,3-oxazol-2-yl)phenyl]-2,4-pyrimidinediamine, exhibiting antiproliferative, anticarcinogenic or antitumor activity |
08/02/2007 | CA2640375A1 Pyrimidine derivatives |
08/02/2007 | CA2636931A1 Piperazines and piperidines as mglur5 potentiators |